BridgeMD
New treatment option for Caregiver Burden
Official title Testing & Refinement of CarePair: An Assessment and Referral Platform to Support Family Caregivers of Alzheimer's Disease and Related Dementias.
ClinicalTrials.gov ID: NCT06418971
What this study is testing
- What it's testing
- The purpose of this study is to develop and test CarePair, a mobile application-based needs assessment and service referral platform for family caregivers of persons with dementia designed to alleviate stress and promote psychosocial well being. The main aims of this study are: To evaluate the feasibility and acceptability of the CarePair mobile application.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older. Healthy volunteers may be eligible.
You may be able to join if
- Inclusion:
- Currently a primary caregiver of a community-dwelling PwD
- Provides at least 10 hours of care per week
- ≥18 years of age
- Fluent in English
See the full eligibility criteria
- Inclusion:
- Currently a primary caregiver of a community-dwelling PwD
- Provides at least 10 hours of care per week
- ≥18 years of age
- Fluent in English
- Both the caregiver and care-recipient reside in and/or can easily access one of the following cities/areas: New York City, New York (NY); Long Island, NY; Westchester County, NY; Seattle, Washington (WA); Los Angeles...
- Provides at least 10 hours of care per week
- Has provided care for at least 6 months
- Able to use the internet and has internet access
- Owns and can operate a smartphone
- Able and willing to provide their informed consent to participate for the six-week study duration
- Does not self-report any cognitive impairments Exclusion:
- Not currently the primary caregiver of a community-dwelling person with dementia
- Care-recipient lives in residential care (e.g., assisted living, skilled nursing facility)
- ≤18 years of age
- Not fluent in English
- The caregiver and/or care-recipient resides outside of and/or cannot easily access any of the following cities: New York City (NY); Long Island (NY); Westchester County (NY); Seattle (WA); Los Angeles (CA)
- Provides less than 10 hours of care per week
- Has provided care for less than 6 months
- Unable to use the internet or does not have internet access
- Does not own and/or cannot operate a smartphone
- Unable or unwilling to provide informed consent to participate for the six-week study duration
- Self-reports having a cognitive impairment
The study team makes the final eligibility decision.
Where it's taking place
- Los Angeles, California, United States
Compensation & support
Compensation likely.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Los Angeles, California, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.